Colorectal Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with colorectal cancer with definite pathological diagnosis; (2) Those who are receiving XELOX regimen as adjuvant chemotherapy; (3) aged 18 to 80 years male and female; (4) At least 4 cycles of XELOX regimen chemotherapy were received after admission into the group; (5) Sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) History of previous or combined malignant tumors, with the exception of cured basal cell carcinoma of the skin and carcinoma in situ of the cervix; (2) Complicated with severe complications of heart, liver and kidney; (3) Patients with intestinal obstruction can not take decoction, need intravenous high-energy nutrition; suffer from malabsorption syndrome or other diseases affecting gastrointestinal absorption, or active peptic ulcer disease; (4) Any unstable situation or situation that may endanger the safety of patients and their compliance with the study; (5) Researchers estimate that the survival time is less than half a year according to the clinical treatment experience and patients'condition; (6) Researchers judged subjects with poor compliance or who could not cooperate in completing the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NCI-CTC; | — |
Secondary
| Measure | Time frame |
|---|---|
| MDASI;Intestinal flora analysis;patient diary; | — |
Countries
China
Contacts
Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine